Clinical Evidence Library

Category: Company News

VivaQuant Inks Collaboration with FDA to Improve Accuracy of Drug Cardiac Safety Assessment

VivaQuant has entered into a five-year collaboration with the FDA to research ways to improve cardiac safety assessment of medications.

VivaQuant Technology Shows Promise for Improving Drug Safety Assessment Accuracy

VivaQuant MDSP technology was the subject of a recent manuscript published in The Journal of Pharmacological and Toxicological Methods (JPTM)

VivaQuant Rhythm Express software demonstrates improved accuracy of cardiac safety assessment markers

Fully automated QT measurements, obtained from VivaQuant Rhythm Express software, with no human review or editing, were shown to improve

VivaQuant and DSI Announce Agreement

Arrangement allows researchers to use the unique VivaQuant algorithms on ECG signals acquired by DSI telemetry and wired acquisition technologies.

VivaQuant Releases AE-1010 Rhythm Express Software

The AE-1010 software provides powerful features and performance for fast, accurate, and efficient analysis and insightful reporting of ECG arrhythmias

VivaQuant Celebrates Eight Years of Success

VivaQuant is celebrating eight years since its founding. In those eight years, VivaQuant is proud to have accomplished these significant

VivaQuant Awarded Federal Funding to Develop a Comfortable, Accurate and Efficient Wearable for Patients with Atrial Fibrillation

The National Institutes of Health has awarded a Phase II SBIR grant to VivaQuant for development of a comfortable, accurate,

Categories